Thu, Aug 21, 2014, 2:11 PM EDT - U.S. Markets close in 1 hr 49 mins

Recent

% | $
Quotes you view appear here for quick access.

Affymax, Inc. (AFFY) Message Board

  • thesavvymonkey777 thesavvymonkey777 Aug 24, 2013 7:25 AM Flag

    Hey, EXP... THANK YOU For Putting The Pieces Together With Today's SA Article!

    Kudos to you, EXP... That latest article that you posted on Seeking Alpha today is a perfect summary of the story of AFFY, Takeda, and OMONTYS. Absolutely outstanding!

    If you folks that hang out on this message board haven't read it yet... DO IT. NOW.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • In case you over looked my message earlier.

      Statistically drugs do get reworked, repurposed and relabeled don't you know. Ask any medical professional and you will be amazed. The original purpose of Viagra was to treat angina ( chest pain associated with poor circulation of the heart ).

      Sometimes as you know, a drug's research or purpose is mis-understood or not administered properly at first. Medicine and biotechnological sciene is highly complex don't you agree?

      Try to follow; let us take Drug A and mix it with Drug B or with product C, a hemodialysis concentrate (solution) ancillary product which in all combinations is very likely similar to having a steel ball bouncing around in a pinball machine. In this case, the pinball machine is the human body. Mixing A, B, and C with the wrong patient (a cancer patient, elderly, or physically weak patient) most probably is where the AE's can present themselves provided the drug "lot" is not contaminated in any way.

      Questcor was such an example and the EXP author was somehow able to research and uncover that unique story in November as I do recall. Was QCOR a pump and dump as some have suggested with Affy on the Seeking Alpha platform? On the contrary if you want to discover for yourselves and check the facts. It was another very nice find for biotech investors like myself searching for mispriced securities by the brokerage firm analysts.

      Many so called savvy wallstreeters missed that golden opportunity.
      Please don't discount the contributions of the intense biotech leadership by our colleagues. An open mind will do wonders. Also, risk is a funny thing too. The risk of being in or not being in at all. Risk is prevalent in all things in life and it is prudent to do your own due diligence of course.

      Sentiment: Strong Buy

    • Incredible. Affymax has been on fire I tell you!!!!!

      Medical malpractice could be the blame.

    • Ladies and gentlemen, statistically drugs do get reworked, repurposed and relabeled don't you know. Ask any medical professional and you will be amazed. The original purpose of Viagra was to treat angina ( chest pain associated with poor circulation of the heart ).

      Sometimes as you know, a drug's research or purpose is mis-understood or not administered properly at first. Medicine and biotechnological sciene is highly complex don't you agree?

      Try to follow; let us take Drug A and mix it with Drug B or with product C, a hemodialysis concentrate (solution) ancillary product which in all combinations is very likely similar to having a steel ball bouncing around in a pinball machine. In this case, the pinball machine is the human body. Mixing A, B, and C with the wrong patient (a cancer patient, elderly, or physically weak patient) most probably is where the AE's can present themselves provided the drug "lot" is not contaminated in any way.

      Questcor was such an example and the EXP author was somehow able to research and uncover that unique story in November as I do recall. Was QCOR a pump and dump as some have suggested with Affy on the Seeking Alpha platform? On the contrary if you want to discover for yourselves and check the facts. It was another very nice find for biotech investors like myself searching for mispriced securities by the brokerage firm analysts.

      Many so called savvy wallstreeters missed that golden opportunity.

      Please don't discount the contributions of the intense biotech leadership by our colleagues. An open mind will do wonders. Also, risk is a funny thing too. The risk of being in or not being in at all. Risk is prevalent in all things in life and it is prudent to do your own due diligence of course.

      Sentiment: Strong Buy

    • The Amgen, Onyx deal should rock the biotech sector this week folks.

      Other trades are setting up too.

      Stay diversified as always.

      Followers please email me as usual.

      TY, EXP

      EXPstocktrader dot commm

      Sentiment: Hold

      • 1 Reply to expstktrader
      • Could this be the first crack in Exp's reputation? Stay diversified as always? I would have expected Exp to be saying mortgage the house, buy all you can, put your entire portfolio in AFFY. Could there be a tinge of conscience in Exp as he takes his profits from pumping this empty shell as he realizes that maybe, just maybe, those who REALLY BELIEVE his story do not understand how a pump and dump actually plays out, and stand to lose most or all of their AFFY "investment" following a buy and hold recommendation for the "big payout"?

    • I agree AFFY is a great short term trade, and a price of slightly more than $2 share is virtually guaranteed near term. The problem arises if this MB and the pumpers have convinced you that AFFY is a "buy and hold" investment for the "big payout" or a multi-bagger. Yes. Read the SA article. Just be sure and also read my replies in that article too.

    • Its looking like next week should be very good again.

      Also, EXPs subscribers get alerts on stock picks from his monthly newsletter and email service. QCOR was on the list again a few weeks ago (trading it from the $20s in and out per the charts and service) and AFFYMAX was written up with some others. If you get it, you know what I mean.

      The service more than pays for itself if you are busy, trade stocks and want some BIG winners.

      Sentiment: Strong Buy

    • I smelled the article on yesterday's price action.

 
AFFY
0.108+0.003(+2.86%)Aug 20 3:51 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.